(Total Views: 351)
Posted On: 06/29/2021 7:07:55 PM
Post# of 145886
I personally don't feel that Janet Woodcock was personally involved in the decision to sideline Leronlimab. This was someone or a few from in the FDA judging the trial or Amarex "helping" with the CD12 trial that were not happy that Merck wasn't the one with the LL.
(0)
(0)